📊 YCBD Key Takeaways
Is cbdMD, Inc. (YCBD) a Good Investment?
cbdMD exhibits a deteriorating operational profile with flat revenue growth and negative operating cash flow, indicating a business in distress despite improving loss margins. While the debt-free balance sheet and strong gross margins (58.7%) provide a safety cushion, the company is burning ~$1.7M annually in free cash flow with only ~15 months of cash runway at current burn rates. Absent demonstrated revenue acceleration or path to operating profitability, the company faces significant execution risk.
cbdMD, Inc. Key Strengths (YCBD)
- Fortress balance sheet with zero long-term debt and 2.82x current ratio ensures near-term solvency
- Healthy 58.7% gross margin indicates product demand and pricing power despite revenue flatness
- Improving loss trajectory (net income up 53.4% YoY, EPS up 92.4%) suggests cost discipline or operational adjustments
YCBD Stock Risks: cbdMD, Inc. Investment Risks
- Negative free cash flow of -$1.7M with flat revenue growth signals unsustainable cash burn and insufficient runway without capital raise
- Operating losses of -$1.1M on $10.7M revenue indicate core business model is not yet viable at scale
- Zero revenue growth (0% YoY) in consumer discretionary sector suggests market headwinds, competitive pressure, or failed commercialization
Key Metrics to Watch
- Revenue growth rate - must inflect positive to 10%+ YoY to justify operations
- Operating cash flow - must turn positive within 2-3 quarters to validate path to breakeven
- Operating margin improvement - trend toward 0% or positive required to demonstrate unit economics viability
cbdMD, Inc. (YCBD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.82x current ratio provides a solid financial cushion.
YCBD Profit Margin, ROE & Profitability Analysis
YCBD vs Consumer Sector: How cbdMD, Inc. Compares
How cbdMD, Inc. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is cbdMD, Inc. Stock Overvalued? YCBD Valuation Analysis 2026
Based on fundamental analysis, cbdMD, Inc. has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
cbdMD, Inc. Balance Sheet: YCBD Debt, Cash & Liquidity
YCBD Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: cbdMD, Inc.'s revenue has declined by 58% over the 5-year period, indicating business contraction. The most recent EPS of $-14.29 indicates the company is currently unprofitable.
YCBD Revenue Growth, EPS Growth & YoY Performance
YCBD Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $4.7M | -$465.7K | N/A |
| Q3 2025 | $4.6M | $15.1K | N/A |
| Q2 2025 | $4.7M | $15.1K | N/A |
| Q1 2025 | $5.0M | $15.1K | N/A |
| Q3 2024 | $5.2M | $459.7K | $-0.15 |
| Q2 2024 | $4.8M | -$996.5K | $-1.35 |
| Q1 2024 | $5.4M | -$996.5K | N/A |
| Q3 2023 | $6.5M | -$1.3M | $-1.16 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
cbdMD, Inc. Dividends, Buybacks & Capital Allocation
YCBD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for cbdMD, Inc. (CIK: 0001644903)
📋 Recent SEC Filings
❓ Frequently Asked Questions about YCBD
What is the AI rating for YCBD?
cbdMD, Inc. (YCBD) has an AI grade of C with 78% confidence, based on fundamental analysis of SEC EDGAR filings.
What are YCBD's key strengths?
Claude: Fortress balance sheet with zero long-term debt and 2.82x current ratio ensures near-term solvency. Healthy 58.7% gross margin indicates product demand and pricing power despite revenue flatness.
What are the risks of investing in YCBD?
Claude: Negative free cash flow of -$1.7M with flat revenue growth signals unsustainable cash burn and insufficient runway without capital raise. Operating losses of -$1.1M on $10.7M revenue indicate core business model is not yet viable at scale.
What is YCBD's revenue and growth?
cbdMD, Inc. reported revenue of $10.7M.
Does YCBD pay dividends?
cbdMD, Inc. pays dividends, with $2.0M distributed to shareholders in the trailing twelve months.
Where can I find YCBD SEC filings?
Official SEC filings for cbdMD, Inc. (CIK: 0001644903) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is YCBD's EPS?
cbdMD, Inc. has a diluted EPS of $-1.09.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is YCBD's fundamental grade?
Based on our AI fundamental analysis in June 2026, cbdMD, Inc. has a C grade with 78% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is YCBD stock overvalued or undervalued?
Valuation metrics for YCBD: ROE of -11.6% (sector avg: 18%), net margin of -10.1% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
What is YCBD's AI grade for 2026?
Our dual AI analysis gives cbdMD, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is YCBD's free cash flow?
cbdMD, Inc.'s operating cash flow is $-1.5M, with capital expenditures of $170.6K. FCF margin is -16.0%.
How does YCBD compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -10.1% (avg: 8%), ROE -11.6% (avg: 18%), current ratio 2.82 (avg: 1.5).